-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Maintains Outperform on Guardian Pharmacy Service, Raises Price Target to $49

Benzinga·08/07/2026 14:09:30
Listen to the news
Oppenheimer analyst Michael Wiederhorn maintains Guardian Pharmacy Service (NYSE:GRDN) with a Outperform and raises the price target from $43 to $49.